Cardiff Study Suggests Targeted Treatment For Leukaemia Group
2/23/2011
Antibody-directed chemotherapy offers improved survival to particular sub-groups of leukaemia sufferers, a Cardiff University-led study has found. The findings suggest that the treatment may be effective for the majority of younger acute myeloid leukaemia (AML) sufferers, who can be identified by genetic profiling...
Novel Methods For Improved Breast Cancer Survival
2/23/2011
A quarter of all women who suffer from breast cancer are at risk of metastasis a recurrence of the cancer. In recent years, researchers at Lund University, Sweden, have developed a technique that can identify in advance which patients belong to this risk group. Within the next two years the method will be tested in Swedish hospitals...
Nanoparticles Increase Survival After Blood Loss
2/23/2011
In an advance that could improve battlefield and trauma care, scientists at Albert Einstein College of Medicine of Yeshiva University have used tiny particles called nanoparticles to improve survival after life-threatening blood loss...
Men's Health Update Covers New BPH, Prostate Cancer Treatments
2/23/2011
The Focused Ultrasound Surgery Foundation has released a special men's heath update in its February 2011 online newsletter. According to the update, tremendous progress being made in developing new minimally-invasive and highly precise treatments for two conditions that afflict millions of men worldwide - prostate cancer and benign prostatic hyperplasia (BPH)...
Relatively lenient regulations regarding human subjects protections in the 1950s played an important role in pediatric oncology being the first field of medicine in which doctors simultaneously treated patients and carried out clinical research, according to a pediatric hematologist-oncologist at the Johns Hopkins Berman Institute of Bioethics. The review, by Yoram Unguru, M.D., M.S., M.A...
Anti-Clotting Agent Does Not Improve Outcomes Of Patients With Severe Pneumonia
2/23/2011
Use of the blood clot-inhibiting medication tifacogin does not appear to improve outcomes of patients with severe community-acquired pneumonia (sCAP), according to a study conducted by researchers from North and South America, Europe, Asia and Africa. The drug had shown some potential benefit in the sCAP subgroup of an earlier trial involving sepsis patients...
Researchers Uncover Pathway That Transforms Normal Cells Into Aggressive Tumors
2/23/2011
A biological pathway that transforms normal cells into aggressive tumors has been discovered by researchers at Cleveland Clinic's Lerner Research Institute. This research, led by Philip Howe, Ph.D., of the Cancer Biology Department of the Lerner Research Institute of Cleveland Clinic, was recently published in Molecular Cell...
Time To Raise How Many Mammograms Radiologists Must Read?
2/23/2011
Radiologists who interpret more mammograms and spend some time reading diagnostic mammograms do better at determining which suspicious breast lesions are cancer, according to a new report published online on February 22 and in print in the April issue of Radiology...
Blocking Enzyme Could Halt Breast Cancer Spread
2/22/2011
Developing a new drug that blocks a key enzyme could stop breast cancer spreading to other parts of the body, according to a new UK study. Dr Janine Erler at the Institute of Cancer Research (ICR) in London, and colleagues, used lab models to show that blocking the enzyme lysyl oxidase-like 2 (LOXL2) reduced the spread of the cancer from the breast to the lungs, liver and bone...
Bone Building Bisphosphonates Reduce Colon Cancer Risk
2/22/2011
A new study shows that bisphosphonates such as Fosamax and Boniva may reduce patients' risk of developing colon cancer. Women in particular tend to take these prescriptions after menopause and now have up to a 59% reduced risk of colon cancer development. Colon cancer affects men and women with equal frequency, but there is a common misperception that it's a "man's disease...